Scalp hypothermia scalp cooling Chemotherapy induced alopecia (CIA) Gynecologic cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -The patients who diagnosed gynecologic cancer such as ovarian cancer, endometrial cancer, cervical cancer and peritoneal cancer including primary or recurrent disease -The patients who planned to receive chemotherapy paclitaxel and platinum based chemotherapy at least 3 cycles -ECOG less than 2
Exclusion criteria
Exclusion criteria: -The patients who had dean score more than 0 before treatment -cold agglutinin disease, cryoglobulinemia and posttraumatic cold dystrophy -previous brain radiotherapy -History of migraines,cluster or tension headache -the patients who receive chemotherapy within 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of Chula cool cap in prevention of hair loss after 3 cycles of chemothery after 3 cycle of chemotherapy dean score | — |
Secondary
| Measure | Time frame |
|---|---|
| The effectiveness of Chula cool cap in prevention of hair loss after 6 cycles of chemotherapy after 6 cycle of chemotherapy dean score,The side effect after receive cool cap following chemotherapy among gynecologic cancer after use chula cool cap every cycle incidence of side effect,The quality of life by EORTC QLQ-30 16-18 body image scale (BIS)19 after finish study scale ,patient’s satisfaction after using Chula scalp cooling cap after use chula cool cap scale,patient to patient recommendation after using Chula scalp cooling cap after use chula cool cap scale | — |
Contacts
Chulolongkorn university